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Background: Uterine leiomyoma is the most common gynecological tumor in the reproductive years. However, it
is extremely rare in adolescence (<1%), with few reports found in the literature. The biological behavior of such
tumors in this age group is unknown, as well as the best possible treatment for this population. We aimed to
analyze all available reports of uterine leiomyoma in adolescence.
Methods: A systematic review was performed at PubMed/MEDLINE and EMBASE. Between 1965 and 2014, 19
reports were found on uterine leiomyoma in patients under 18 years. The following parameters were discussed:
age, tumor diameter, symptoms, clinical treatments, surgical treatments, hemodynamic changes.
Results: Mean age was 15.35 (14–17) years. Mean tumor diameter was 12.28 cm (3–30) and median diameter was
10 cm. Most patients presented with symptoms (87.5%), including abnormal uterine bleeding (10/18) and pelvic/
abdominal pain (6/18). A pelvic mass was the most common finding. Two patients required transfusion due to anemia.
One patient underwent abdominal hysterectomy, and the others underwent myomectomy. Mean follow-up was 1 year
and 8 months, and only case recurred, after 6 months.
Conclusion: Leiomyomas’ biologic behavior in adolescents may be different from that of older women, but their
molecular characteristics still haven’t been analyzed. Optimal treatment is still not defined, but myomectomy has
several advantages in this population. Leiomyomas must be remembered as an important differential diagnosis of
pelvic mass in adolescents.
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Uterine leiomyomas, or fibroids, are benign tumors ori-
ginating from smooth muscle cells of the uterine wall.
They are exceedingly common among women of repro-
ductive age, and it’s estimated that about 60% to 80% of
women may be affected at 50 years of age. The etiology of
such tumors is not well understood, but it is known that
they share a monoclonal origin, i.e. they are derived from
a single precursor cell. The mechanism by which these le-
sions rise is not known, but many factors are recognized
as growth promoters, with sex steroids being the most fre-
quently studied.* Correspondence: lgobrito@gmail.com
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unless otherwise stated.Many risk factors are associated with the development
of fibroids, such as nulliparity, obesity and early menar-
che, with a greater exposure to sex steroids, especially
estrogen, as the alleged mechanism by which they exert
such action [1]. Although they are very common among
women in general, leiomyomas are infrequently diag-
nosed in children and adolescents, with few reported
cases in the literature. Nevertheless, they are important
differential diagnoses in adolescents with pelvic masses.
The present review aims at analyzing the reported cases
of fibroids in adolescents and discuss the therapeutic
strategies employed in these cases.Methods
A search was conducted on the PubMed/MEDLINE data-
base with the string ‘(“uterine leiomyoma” OR “uterine fi-
broids”) AND adolescent’ (without the external quotes),. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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leiomyoma*” OR “uterine fibroid*”) AND adolescent*.
There were 104 results found, among which 9 case reports
of fibroids in adolescents were identified. Full texts of
these reports were obtained and their reference lists were
reviewed, leading to another 10 cases, comprising a total
of 19 reports of leiomyomas in adolescents (Figure 1).
Cases included were those reporting fibroids in women
younger than 18 years of age.
Results
Literature search led to 19 case reports of fibroids [2-20]
among adolescents (Table 1). The first reported case was
made by Wisot et al. in 1969, in which a 15 year old girl
underwent an abdominal myomectomy due to intenseFigure 1 PRISMA 2009 flow diagram.vaginal bleeding and to a pelvic mass suspicious for leio-
myosarcoma. There was a recurrence of the lesion six
months after surgery [2].
Since then, some reports were published on fibroids in
this specific population. In 1981, Augensen et al. described
the case of a 15 year old patient that presented with abnor-
mal uterine bleeding, urinary retention and an abdominal
mass [3]. She underwent an abdominal myomectomy, with
the intraoperative finding of a 10 cm leiomyoma, and was
free of disease after one year of follow-up. In 1986, a new
case was published by De Rooy et al., describing another
15 year old adolescent who presented with hemorrhagic
shock two days after the diagnosis of a pelvic mass suspi-
cious for leiomyoma. Abdominal myomectomy was the of-
fered treatment after an emergency laparotomy, although
Table 1 Reported cases of uterine leiomyoma in adolescents listed in chronological order
Author Age Year Clinical picture Treatment Tumor size (cm)
Wisot et al. [2] 15 1969 AUB; pelvic mass Abdominal myomectomy Not informed
Augensen [3] 15 1981 AUB; pelvic mass; urinary retention Abdominal myomectomy 10
De Rooy et al. [4] 15 1986 AUB; abdominal mass Abdominal myomectomy 16
Horejsi et al. [8] 15 1988 Not Informed Abdominal Hysterectomy + BSO Not Informed
Heimer et al. [14] 15 1991 Abdominal pain; fatigue Abdominal myomectomy 17
Morad et al. [10] 15 1993 AUB; abdominal mass Abdominal myomectomy 7
Fields et al. [6] 16 1996 22 weeks pregnant; periumbilical pain Expectation Not informed
Nguyen Duc et al. [18] 15 2003 AUB; abdominal mass; anemia Not informed Not informed
Bekker et al. [11] 15 2004 AUB; abdominal pain Abdominal myomectomy 26
Grapsa et al. [13] 16 2006 AUB; abdominal mass Abdominal myomectomy 30
Diesen et al. [12] 14 2008 Dysmenorrhea; abdominal
distention
Abdominal myomectomy 15
Perkins et al. [17] 17 2009 Pelvic mass Abdominal myomectomy 10
Karim et al. [19] 16 2010 Pelvic mass; increased abdominal volume Abdominal myomectomy 25
Khorrami et al. [7] 17 2011 AUB; refractory anemia Hysteroscopic myomectomy 3
Taskin et al. [5] 16 2011 Pelvic mass; mass protruding
through vaginal opening
Hysteroscopic myomectomy 4
Wright et al. [9] 14 2011 AUB; abdominal pain; increased
abdominal volume
Abdominal myomectomy 12





Perez-Colon et al. [16] 15 2011 AUB Not Informed 5
Kayadibi et al. [20] 15 2014 Pelvic mass; increased abdominal volume Abdominal myomectomy 20
AUB – abnormal uterine bleeding; BSO – bilateral salpingoophorectomy.
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Histopathology of the lesion diagnosed leiomyoma and there
was no recurrence after 5 years of follow-up [4].
Among identified cases, average age was 15.35 years
(14–17 years), mean diameter was 12.28 cm (3–30 cm)
and median diameter was 10 cm. Most patients presented
with symptoms (87.5%), the most frequent ones being in-
creased uterine bleeding in frequency and/or intensity
(10/18), abdominal pain (6/18) and perception of abdom-
inal mass or increased abdominal volume (8/18). One of
the patients had, as initial presentation, the exteriorization
of a mass through the vaginal introitus, without any other
complaints [5]. Another patient was pregnant when diag-
nosed, and was complaining only of periumbilical pain [6].
Three patients had symptoms related to anemia, with two
them eventually needing transfusion. One patient pre-
sented with urinary retention due to compression by the
enlarged fibroid [3].
Almost all patients were managed through myomec-
tomy (88.2%), with two of them performed hysteroscopi-
cally [5,7]. Horejsi et al. reported on the case of a
15 year old patient who underwent a hysterectomy with
bilateral salpingoophorectomy in 1988. A radical proced-
ure was indicated due to the extension of the lesion and
the presence of severe adhesions, according to thereporting authors, with no further details [8]. Wright
et al. described the case of a 14 year old adolescent with
abnormal uterine bleeding, pain and increased abdom-
inal volume, in which a large fibroid (16 cm in diameter)
was removed through an abdominal myomectomy and
the patient was given a continuous progestagen postop-
eratively. After 6 months, there was recurrence of the
disease, with an 11 cm tumor identified. A new myo-
mectomy was performed, this time robotically, after
which another recurrence was observed, with a smaller
3 cm tumor. Expectant management was offered and the
patient followed-up for one year with no alterations [9].
Another report, by Morad et al., described a 15 year old
adolescent, who underwent abdominal myomectomy for
a 7-cm tumor and became pregnant after 8 months of
follow-up. There were no adverse events during preg-
nancy or delivery, which was carried out by cesarean
[10]. The patient that was already pregnant at diagnosis
was expectantly managed, with no intervention. Preg-
nancy outcome, however, was not reported [6]. In one of
the hysteroscopic myomectomies reported, vaginal resec-
tion of a partly exteriorized leiomyoma was performed be-
fore completing the hysteroscopic resection [5].
Average follow-up was 1 year and 8 months (3 months
to 6 years), and only one recurrence was reported, which
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cases were managed with medical treatments and, apart
from the two hysteroscopic resections, no other minim-
ally invasive non-surgical techniques (uterine artery
embolization, magnetic resonance guided focused ultra-
sound) was employed.
Discussion
The observation of symptomatic uterine fibroids among
pediatric and adolescent population is an uncommon
event. Thus, the characteristics of such disease in this spe-
cific group are not well known, and the most appropriate
treatment is still not defined.
The etiology of uterine fibroids is generally unknown. It is
known that they are monoclonal tumors, originating from a
single cell that transformed and became neoplastic, and
that almost half of them show chromosomal abnormalities
[1]. In one of the reported cases, cytogenetic study was
performed in the resected tumor, and a translocation be-
tween chromosomes 12 and 14 was identified [9]. Such
translocation is one of the genetic aberrations commonly
found in these tumors [21]. The precise factor that sets in
motion a chain of events that lead to leiomyoma forma-
tion, however, is still unknown. Consequently, it is also
unknown if the cases occurring in adolescents are related
to some specific factor or not. It has been suggested that
leiomyomas might originate from intrinsic anomalies in
the myometrium; from congenitally elevated levels of sex
steroids; and from endometrial injury acquired during
menstruation [1]. Any of these theories can justify the ap-
pearance of such tumors in adolescents, after menarche,
when endometrial sloughing and sex steroid exposition
have already occurred, but they don’t explain the reasons
why the lesions appeared sooner, rather than later in
adulthood. The authors of one of the reports have theo-
rized that the lesions were probably already present from
an early age, or were congenitally acquired, and develop-
ment occurred after menarche due to sex steroid stimula-
tion [4], which is a plausible hypothesis, but one that lacks
any evidence. The few reported cases contribute to this
lack of knowledge.
Clinical presentation of uterine leiomyomas varies in
any age, depending on individual characteristics of the tu-
mors and the women affected. It is estimated that about
50% of uterine fibroids are asymptomatic, which is prob-
ably an understatement due to the great number of un-
diagnosed cases [22]. Among symptomatic women, the
most frequently observed complaints are irregular or in-
tense uterine bleeding, pelvic pain and symptoms related
to compression by the tumors, such as urinary frequency
or urgency. The presentation of such lesions among ado-
lescents doesn’t seem to differ from the general popula-
tion of women. Most reported cases showed symptomatic
adolescents (87.5%). The number of reports, however, issmall and the possibility of a significant number of un-
diagnosed cases or of expectantly managed asymptomatic
cases among adolescents must be taken into account. An
estimate may be drawn from an epidemiologic survey in-
volving 21,479 women in 8 countries, which were evalu-
ated through an online questionnaire. The study included
2,180 adolescents aged 15 to 19 years, among whom the
estimated prevalence of leiomyoma based on self-reported
diagnosis was 0.4% [23]. Such prevalence, despite being
low, contrasts with the minimal number of symptomatic
cases reported. It is possible that most teenagers who an-
swered the survey don’t experience disturbing symptoms
that justify seeking medical care.
Differential diagnosis of these tumors in adolescents is
important. An increase in abdominal volume due to a pel-
vic mass in this age group must always alert the attending
physician to the possibility of an adnexal tumor. In one of
the reported cases, a large lesion, with 30 cm in diameter,
was initially interpreted as an ovarian neoplasm and only
during laparotomy the diagnosis of uterine leiomyoma
was made and a myomectomy carried out [13]. Other
tumors originating from the body of the uterus might also
affect teenagers and must be remembered. Müllerian
adenosarcomas are low grade tumors, most commonly
observed in elderly women, but a series of nine cases af-
fecting adolescents was reported by Andrade et al., who
described uterine bleeding and the exteriorization of a
tumor through the vaginal introitus as the main present-
ing findings [24]. Cases in which a leiomyoma protrudes
through the cervix in adolescents must also be differenti-
ated from Sarcoma Botryoides, a rare tumor originating
from the vaginal mucosa, which affects mainly children
and adolescents, and presents through the appearance of a
mass in the vaginal opening. It is the most common vagi-
nal neoplasia in girls up to 10 years-old [5].
Regarding the treatment of leiomyomas occurring dur-
ing adolescence, experience is limited to the published
cases, and there are no guidelines that shed light specif-
ically on this situation. Amidst the reported cases, all pa-
tients that were treated had their leiomyomas resected
with uterine preservation, with the objective of preserv-
ing fertility, except for one patient, in which a radical
surgery was performed, but the reason for such treat-
ment were not clear. However, surgical treatment has
not been the only option to offer symptomatic women.
Medical treatments and minimally invasive techniques
are available and are routinely used in reproductive aged
women. The use of such treatments in adolescents, how-
ever, lacks any evidence, and little is known about their
applicability in this group of patients.
Since leiomyomas are such an uncommon finding in this
young population, the treatment offered to the few symp-
tomatic cases encountered was extrapolated from that of-
fered to older reproductive aged women. Myomectomy,
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ment, since it is durable, owing to the low recurrence rates
of fibroids, preserves fertility, and doesn’t interfere with the
hormonal milieu of the developing teenager. As for the real
incidence of such disease in this population, although 85%
of the treated adolescents of the reports presented with
symptoms, it must be remembered that they represent a
selected population, which sought medical care due to
their complaints. An epidemiological survey estimates a
prevalence of 0.4% of such disease among teenagers. Con-
sequently, as it occurs in older women, most adolescents
with leiomyomas are probably asymptomatic.
Newer treatments for uterine fibroids have been de-
veloped, but we don’t know if they will be efficient for
adolescents. Ulipristal is a selective progesterone recep-
tor modulator (SPRM) have been successful to reach
amenorrhea in 70-80% of women, with a faster median
onset of 4 days to reach it and less adverse effects when
compared to GnRH analogues [25]; however, this drug
was not tested in women under 18 years. Aromatase in-
hibitors are similar to GnRH analogs; however, they were
not tested in a younger population in trials that were per-
formed [26]. Other minimally techniques, such as uterine
artery embolization (UAE) and high-intensity focused
ultrasound (HIFU), have shown high rates of efficacy in
women over 18 years, with no case series in women under
18 years with abnormal bleeding secondary to fibroids;
only one case was reported about UAE in a 12-year-old
girl with an hematological disorder and life threatening
heavy menstrual bleeding successfully treated [27].
Conclusion
Certainly, it is noted that leiomyomas’ biologic behavior in
adolescents seems to be different from that of older women,
but their molecular characteristics still haven’t been ana-
lyzed. Biological studies should be performed in order to de-
termine whether are differences among its pathophysiology.
Optimal treatment is still not defined, but myomectomy has
several advantages in this population, considering their pos-
sible fertility plans. And last but not least, leiomyomas must
be remembered as an important differential diagnosis of pel-
vic mass in adolescents.
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